AKTX - Akari Therapeutics Projected Sales Volume

Akari Therapeutics Plc - graphic logo of issuer AKTX

The reliability of Akari Therapeutics (AKTX) is based on outsourcing bioprotein production to certified CDMO plants. The projected sales volume confirms this stability, where 0.00 reflects the latest metric value. The development vector is set by a team striving for success in the therapy of rare autoimmune pathologies, while investors closely monitor asset optimization and the management's strategic deals.

AKTX - Akari Therapeutics Projected Sales Volume over the range 07/04/2022 - 11/18/2026

Analytical breakdowns for Akari Therapeutics

- stock value and consensus price forecast:
Fundamental valuation:Akari Therapeutics PLC
Brand item of Akari Therapeutics plc

This indicator assesses the commercial growth potential of the issuer, identifying hidden business vulnerabilities during periods of market optimism. Investors determine asset resilience by analyzing the company's projected future revenue for a series of stable peaks. The metric measures the actual ability to generate cash flows, preventing an unjustified overpayment for the asset. For Akari Therapeutics (AKTX), this forecast relies on the efficiency of production outsourcing via CDMO plants. Such a model minimizes operational risks, directly influencing the dynamics of this chart.

Main competitors

Company Projected Revenue Argenx (ARGX)|BioNTech - Company Revenue Forecast|Projected Sales Volume ABVX (Abivax)|ADMA Bio (ADMA) - Company Expected Sales Volume|PTGX - Company Projected Revenue|Company Future Sales immunovant.com IMVT|KNSA: Projected Sales Volume|Grifols - Company Future Revenue|ADPT (Adaptive Biotech) - Projected Sales Volume|Company Projected Revenue CLDX|Projected Sales Volume AUPH|Company Future Sales Volume biocryst.com BCRX|Vera Therapeutics - Company Future Sales Volume|Company Projected Revenue Volume DNTH (Dianthus Therapeutics, Inc.)|Pharvaris NV - Projected Sales Volume|ABCL: Company Projected Revenue|Tourmaline Bio, Inc. (TRML) - Company Projected Revenue|Company Expected Sales Volume precigen.com (PGEN)|PHAR (pharming.com) - Projected Sales Volume|NKTR (Nektar Therapeutics Inc.) - Company Projected Revenue Volume|Projected Sales Volume UPB|ZBIO - Company Expected Sales Volume|Projected Sales Volume IMNM (immunome.com)|Gossamer Bio, Inc. - Company Projected Revenue|KalVista Pharmaceuticals, Inc. - Projected Sales Volume|SEPN (Septerna) - Company Revenue Forecast|Pieris Corp (PVLA) - Company Projected Revenue|SVRA - Company Future Sales|RIGL (rigel.com) - Projected Sales Volume|Company Revenue Forecast ANAB (AnaptysBio, Inc.)|Projected Sales Volume ATXS|enGene Holdings Inc (ENGN) - Company Sales Forecast|Projected Sales Volume RAPT (RAPT Therapeutics Inc.)|JBIO (Aerovate) - Company Expected Revenue|ACRS: Company Future Sales Volume|KYTX - Projected Sales Volume|TLSA: Projected Sales Volume|Company Future Sales Volume Cabaletta Bio, Inc|Company Projected Revenue Ventyx Biosciences, Inc|THTX: Company Future Revenue|Company Future Sales Volume AVTX (Avalo Therapeutics, Inc)|Company Future Sales Volume Eledon Pharmaceuticals ELDN|Company Projected Revenue Agenus, Inc. AGEN|Projected Sales Volume Climb Bio Inc. CLYM|ZURA - Company Projected Revenue|Company Expected Revenue ATYR|ADAG (Adagene Inc.) - Company Future Sales Volume|ImageneBio Inc (IMA) - Projected Sales Volume|Company Projected Revenue Shattuck Therapeutics|Company Future Sales Volume equilliumbio.com (EQ)|Projected Sales Volume CNTB|Company Future Sales Immunic Therapeutics|Projected Sales Volume ATRA (Atara Biotherapeutics, Inc.)|IFRX - Company Future Sales Volume|Company Future Revenue X4 Pharmaceuticals, Inc. (XFOR)|ACET (adicetbio.com) - Company Revenue Forecast|CELU: Projected Sales Volume|INMB - Company Future Sales|Company Projected Revenue Barinthus Biotherapeutics plc|KZR: Company Future Revenue|Projected Sales Volume SABS|Company Future Sales Volume Enlivex Therapeutics Ltd. ENLV|Q32 Bio Corp - Company Future Sales Volume|GOVX - Company Future Sales Volume|EDSA - Company Projected Revenue|Company Future Revenue IBIO (iBio, Inc.)|CARM: Projected Sales Volume|XTL Biopharmaceuticals, Ltd. (XTLB) - Projected Sales Volume|Company Projected Revenue boltbio.com|Projected Sales Volume hcwbiologics.com|Company Future Sales Volume APVO (aptevotherapeutics.com)|Company Future Sales AIM ImmunoTech, Inc.|Projected Sales Volume ADTX (Aditxt)|Company Future Revenue GRI|XRTX - Company Projected Revenue|HIND: Company Projected Revenue|REVB (Revelation Biosciences Corp) - Company Future Sales Volume|Company Revenue Forecast INDP|Company Projected Revenue Scinai Immunotherapeutics Ltd|calcimedica.com (CALI) - Company Future Sales|Company Projected Revenue Affimed NV (AFMD)|Allakos - Company Revenue Forecast|Company Projected Revenue HOOKIPA Pharma, Inc. HOOK|IGMS - Company Future Sales Volume|ITOS: Company Future Sales Volume|Company Expected Sales Volume Ocean Biomedical|TCBP: Projected Sales Volume|Third Harmonic Bio, Inc - Company Future Revenue